HTG), provider of the quantitative Nuclease Protection Assay (qNPA[TM]), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay).
What does qNPA stand for?
qNPA stands for Quantitative Nuclease Protection Assay
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Quantitative Nuclear Magnetic Resonance
- Qualified New Neighbor (State Farm)
- Quality News Network (radio station)
- Qatar National Olympic Committee
- QuadNine Productions
- Quantified Noun Phrase (linguistics)
- Quark Nuclear Physics
- Queen's Knight Pawn (chess)
- Queensland Newspapers (Brisbane, Australia)
- Query Node Patterns
- Quality Network Planned Maintenance (GM)
- Queensland National Parks and Wildlife Service (Australia)
- Quality Assurance and Quality Control
- Approaching Point of No Return (aviation radio Q-signal)
- Quail Neural Retina (cells)
- Quasi-Newton-Raphson (scientific method)
- Quality of Natural Resources Commission (Gastonia, NC)
- Quantization Noise Reduction with In-Band Filtering (electrical engineering)
- Queensland Natural Resources and Mines (Australia)
Samples in periodicals archive:
HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have entered into a supply agreement.
provider of the quantitative Nuclease Protection Assay (qNPA[TM]) today announced the launch of the quantitative Nuclease protection assay (qNPA[TM]) 96 Max gene expression assay at the American Association of Cancer Research (AACR) annual meeting.
provider of the quantitative Nuclease Protection Assay (qNPA[TM]) system and service partner for the life sciences industry, today announced a collaboration agreement with researchers at Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT) at Harvard Medical School.
Quantitative Nuclease Protection Assay Testing Method Offers High Throughput and Cost Effective Results for Evaluating Toxicity Markers TUCSON, Ariz.
HTG's ArrayPlate lysis-only quantitative Nuclease Protection Assay (qNPA(TM)) platform allows scientists to test any sample while avoiding the need for extraction or target amplification.
Craig Rine and Michael Angarita will be responsible for sales and support of HTG's quantitative Nuclease Protection Assay (qNPA(TM)) technology in the Northeast and Midwest, respectively.
The new ArrayPlate 384-4 platform offering is based on HTG's self-customized quantitative Nuclease Protection Assay (qNPA(TM)) technology, which allows researchers to test any sample type, including fixed tissue, using small sample sizes while avoiding the need for extraction, reverse transcription or amplification.